Alleles with short CAG and GGN repeats in the androgen receptor gene are associated with benign endometrial cancer

International Journal of Cancer

Volumn 118, Issue 6, 2006, Pages 1420-1425

  Rodríguez, German ^a,b   Bilbao, Cristina ^a,b   Ramírez, Raquel ^a,b   Falcón, Orlando ^a,c,d   León, Laureano ^a,c   Chirino, Ricardo ^a,b   Falcón Jr , Orlando ^a,c   Pilar Diaz B ^a,b   Rivero, Juan F ^a   Perucho, Manuel ^e   Nicolas Diaz Chico B ^a,b   Díaz Chico, Juan C ^a,b  

^a Madrid Spain   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^c Hospital Universitario Materno Infantil de Canarias   (Spain)

^d Institute Ginecológico Dr Falcón   (Spain)

^e BURNHAM INSTITUTE   (United States)

Author keywords

Polymorphism; Prognostic variable; Steroid dependent tumor

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; DNA; RECEPTOR PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; DNA SEQUENCE; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; FEMALE; GENOTYPE; HISTOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR GENE; TRINUCLEOTIDE REPEAT; X CHROMOSOME;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ENDOMETRIAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; KAPLAN-MEIER ESTIMATE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, ANDROGEN; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; TRINUCLEOTIDE REPEAT EXPANSION; TRINUCLEOTIDE REPEATS;

EID: 33644601177     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21516     Document Type: Article

References (41)

1. Brinkmann AO, Faber PW, van Rooij HC, Kuiper GG, Ris C, Klaassen P, van der Korput JA, Voorhorst MM, van Laar JH, Mulder E. The human androgen receptor: domain structure, genomic organization and regulation of expression. J Steroid Biochem 1989;34:307-10.
2. Jenster G, van der Korput HA, Trapman J, Brinkmann AO. Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem 1995;31:7341-6.
3. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994;22:3181-6.
4. Ding D, Xu L, Menon M, Reddy GP, Barrack ER. Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action. Prostate 2005;62:133-9.
5. Yu H, Bharaj B, Vassilikos EJ, Giai M, Diamandis EP. Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer. Breast Cancer Res Treat 2000;59:153-61.
6. Giguere Y, Dewailly E, Brisson J, Ayotte P, Laflamme N, Demers A, Forest VI, Dodin S, Robert J, Rousseau F. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population. Cancer Res 2001;61:5869-74.
7. Levine DA, Boyd J. The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series. Cancer Res 2001;61:908-11.
8. Montgomery JS, Price DK, Figg WD. The androgen receptor gene and its influence on the development and progression of prostate cancer. J Pathol 2001;195:138-46.
9. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A, Talcott J, Hennekens CH, Kantoff PW. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 1997;94:3320-3.
10. Edwards SM, Badzioch MD, Minter R, Hamoudi R, Collins N, Ardern-Jones A, Dowe A, Osborne S, Kelly J, Shearer R, Easton DF, Saunders GF, et al. Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival. Int J Cancer 1999;84:458-65.
11. Bennett CL, Price DK, Kim S, Liu D, Jovanovic BD, Nathan D, Johnson ME, Montgomery JS, Cude K, Brockbank JC, Sartor O, Figg WD. Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status. J Clin Oncol 2002;20:3599-604.
12. Li AJ, Baldwin RL, Karlan BY. Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma. Clin Cancer Res 2003;9:3667-73.
13. IARC. Cancer incidence in five continents, vol. VIII. IARC Sci Publ 2002;155:1-781.
14. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
15. Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S, Krogh V, Lenner P, Shore RE, Biessy C, Muti P, Riboli E, et al. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer 2004;108:425-32.
16. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002;11:1531-43.
17. Horie K, Takakura K, Imai K, Liao S, Mori T. Immunohistochemical localization of androgen receptor in the human endometrium, decidua, placenta and pathological conditions of the endometrium. Hum Reprod 1992;7:1461-6.
18. Ito K, Suzuki T, Akahira J, Moriya T, Kaneko C, Utsunomiya H, Yaegashi N, Okamura K, Sasano H. Expression of androgen receptor and 5α-reductases in the human normal endometrium and its disorders. Int J Cancer 2002;99:652-7.
19. Hackenberg R, Beck S, Filmer A, Hushmand Nia A, Kunzmann R, Koch M, Slater EP, Schulz KD. Androgen responsiveness of the new human endometrial cancer cell line MFE-296. Int J Cancer 1994;57:117-22.
20. Tuckerman EM, Okon MA, Li T, Laird SM. Do androgens have a direct effect on endometrial function? An in vitro study. Fertil Steril 2000;74:771-9.
21. Sasaki M, Sakuragi N, Dahiya R. The CAG repeats in exon 1 of the androgen receptor gene are significantly longer in endometrial cancer patients. Biochem Biophys Res Commun 2003;305:1105-8.
22. Sasaki M. Karube A, Karabe Y, Watari M, Sakuragi N, Fujimoto S, Dahiya R. GGC and StuI polymorphism on the androgen receptor gene in endometrial cancer patients. Biochem Biophys Res Commun 2005;329:100-4.
23. Yaron M, Levy T, Chetrit A, Levavi H, Sabah G, Schneider D, Halperin R, Ben-Rafael Z, Friedman E. The polymorphic CAG repeat in the androgen receptor gene in Jewish Israeli women with endometrial carcinoma. Cancer 2001;92:1190-4.
24. Sleddens HF, Oostra BA, Brinkmann AO, Trapman J. Trinucleotide (GGN) repeat polymorphism in the human androgen receptor (AR) gene. Hum Mol Genet 1993;2:493.
25. Bharaj BS, Vassilikos EJ, Diamandis EP. Rapid and accurate determination of (CAG)n repeats in the androgen receptor gene using polymerase chain reaction and automated fragment analysis. Clin Biochem 1999;32:327-32.
26. Boorman DW, Guo Y, Visvanathan K, Helzlsouer K, O'Brien TG. Automated fragment analysis method for determining androgen receptor CAG repeat length. Biotechniques 2002;33:140-3.
27. Delmotte F, Leterme N, Simon JC. Microsatellite allele sizing: difference between automated capillary electrophoresis and manual technique. Biotechniques 2001;3l:810,814-16,818.
28. Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang C. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res 2000;60:5111-6.
29. Hardy DO, Scher HI, Bogenreider T, Sabbatini P, Zhang ZF, Nanus DM, Catterall JF. Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. J Clin Endocrinol Metab 1996;81:4400-5.
30. Kittles RA, Young D, Weinrich S, Hudson J, Argyropoulos G, Ukoli F, Adams-Campbell L, Dunston GM. Extent of linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in human populations: implications for prostate cancer risk. Hum Genet 2001;109:253-61.
31. Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 1995;55:1937-40.
32. Sasaki M, Kaneuchi M, Sakuragi N, Fujimoto S, Carroll PR, Dahiya R. The polyglycine and polyglutamine repeats in the androgen receptor gene in Japanese and Caucasian populations. Biochem Biophys Res Commun 2003;312:1244-7.
33. Esteban E, Dugoujon JM, Valveny N, Gonzalez-Reimers E, Moral P. Spanish and African contribution to the genetic pool of the Canary islanders: data from GM and KM haplotypes and RFLPs in the immunoglobulin IGHG loci. Ann Hum Genet 1998;62:33-45.
34. Flores C, Maca-Meyer N, Perez JA, Cabrera VM. The peopling of the Canary Islands: a CD4/Alu microsatellite haplotype perspective. Hum Immunol 2001;62:949-53.
35. Maca-Meyer N, Villar J, Perez-Mendez L, Cabrera de Leon A, Flores C. A tale of aborigines, conquerors and slaves: Alu insertion polymorphisms and the peopling of Canary Islands. Ann Hum Genet 2004;68:600-5.
36. Hakimi JM, Schoenberg MP, Rondinelli RH, Piantadosi S, Barrack ER. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin Cancer Res 1997;3:1599-608.
37. Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA, Ostrander EA. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 1997;57:1194-8.
38. Correa-Cerro L, Wohr G, Haussler J, Berthon P, Drelon E, Mangin P, Fournier G, Cussenot O, Kraus P, Just W, Paiss T, Cantu JM, et al. (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. Eur J Hum Genet 1999;7:357-62.
39. Beilin J, Harewood L, Frydenberg M, Mameghan H, Martyres RF, Farish SJ, Yue C, Deam DR, Byron KA, Zajac JD. A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects. Cancer 2001;92:941-9.
40. Navarro D, Luzardo OP, Fernandez L, Chesa N, Diaz-Chico BN. Transition to androgen-independence in prostate cancer. J Steroid Biochem Mol Biol 2002;81:191-201.
41. Sasaki M, Dahiya R, Fujimoto S, Ishikawa M, Oshimura M. The expansion of the CAG repeat in exon 1 of the human androgen receptor gene is associated with uterine endometrial carcinoma. Mol Carcinog 2000;27:237-44.